When did reform become about avoiding the bad outcomes it intentionally creates?

October 31, 2022 Latest News BioPharma Comment

This is a preview of subscriber content

Subscribe now to continue reading.

It is a shocking indictment of the state of policy-making that a major round of reform directs most of its energy at managing the bad outcomes it intentionally creates. …

Subscribe now to continue reading.

Latest Video

Rebates are bad enough without invoices based on unconstitutional benefit claims
November 4, 2025 - Latest News
Sandoz launches PBS-listed ADHD medicine to help ease national supply shortages
November 4, 2025 - Latest News
Hong Kong positions itself as a global bridge for biotech and life sciences innovation
November 5, 2025 - Latest News
NDIS growth begins to slow but spending still tops $46 billion
November 5, 2025 - Latest News
Dr Andrée Bates on pharma’s real AI challenge - if the technology is ready, why isn’t the culture?
November 4, 2025 - Latest News

When did reform become about avoiding the bad outcomes it intentionally creates?

This is a preview of subscriber content

Latest Video

Most Read

Rebates are bad enough without invoices based on unconstitutional benefit claims

Sandoz launches PBS-listed ADHD medicine to help ease national supply shortages

Hong Kong positions itself as a global bridge for biotech and life sciences innovation

NDIS growth begins to slow but spending still tops $46 billion

Dr Andrée Bates on pharma’s real AI challenge - if the technology is ready, why isn’t the culture?

New Stories

Donald Trump announces 'MFN' deals with Lilly and Novo Nordisk and end to 'global freeloading'

Sanofi employees contribute over 400 volunteer hours to community and environmental causes

Neuren posts record royalties as DAYBUE sales surpass US$100 million in third quarter

US Ambassador warns UK risks losing pharma investment unless it pays more for medicines

Pfizer to continue legal fight as court rejects bid to block Novo Nordisk’s Metsera takeover bid

What next for PBS rebate system amid constitutional breaches, disputed claims, and global pressure?

Linda Burney to chair new First Nations Pharmacy Network

Sign In

When did reform become about avoiding the bad outcomes it intentionally creates?

This is a preview of subscriber content

Latest Video

Most Read

Rebates are bad enough without invoices based on unconstitutional benefit claims

Sandoz launches PBS-listed ADHD medicine to help ease national supply shortages

Hong Kong positions itself as a global bridge for biotech and life sciences innovation

NDIS growth begins to slow but spending still tops $46 billion

Dr Andrée Bates on pharma’s real AI challenge - if the technology is ready, why isn’t the culture?

Follow Us

New Stories

Donald Trump announces 'MFN' deals with Lilly and Novo Nordisk and end to 'global freeloading'

Sanofi employees contribute over 400 volunteer hours to community and environmental causes

Neuren posts record royalties as DAYBUE sales surpass US$100 million in third quarter

US Ambassador warns UK risks losing pharma investment unless it pays more for medicines

Pfizer to continue legal fight as court rejects bid to block Novo Nordisk’s Metsera takeover bid

What next for PBS rebate system amid constitutional breaches, disputed claims, and global pressure?

Linda Burney to chair new First Nations Pharmacy Network